Blog

Blog2023-08-08T17:17:12-04:00

Meta-Analysis: Antipsychotics and Pregnancy Outcomes

Second-generation or “atypical” antipsychotics, such as olanzapine (Zyprexa), aripiprazole (Abilify), and risperidone (Risperdal), are used far more frequently than are the first-generation or “typical” antipsychotics, such as haloperidol (Haldol). This is largely because the newer agents are associated with fewer side effects and, as a result, have been used for a wider spectrum of illnesses, including bipolar disorder, anxiety disorders, and obsessive compulsive disorder, in addition to chronic psychotic illnesses such [...]

May 6th, 2015|

The Immense Burden of Menopausal Symptoms

Several recent articles suggest that the burden of menopausal symptoms is greater than generally perceived.  About 80% of women experience vasomotor symptoms (VMS) – hot flashes and night sweats -- as they transition into the menopause phase.  For most, the symptoms are manageable, but for a sizeable subset of midlife women, these symptoms can negatively affect sleep, mood, and quality of life.  While clinical guidelines suggest that menopausal vasomotor symptoms (VMS) [...]

May 4th, 2015|

Climb Out of Darkness: Support Women with Perinatal Mood and Anxiety Disorders

Katherine Stone, the founder of Postpartum Progress, has long been an advocate for women with perinatal mood and anxiety disorders.  In addition to her website which provides information and support, she has helped to create and sponsor events which raise public awareness of postpartum depression and related disorders.  The largest event for women with perinatal mood and anxiety disorders — Climb Out of the Darkness 2015 – willl take place on June 20th.

May 1st, 2015|

Anxiety During Pregnancy: Options for Treatment

Anxiety symptoms are relatively common during pregnancy but typically undiagnosed and undertreated.  A recent study of 2793 women observed that 9.5% of women meet criteria for generalized anxiety disorder (GAD) at some point during their pregnancy.  The highest rates of GAD were observed in the first trimester (7%). Only 2% of women met criteria for GAD in the second trimester, and 3% in the third trimester.

April 30th, 2015|
Go to Top